Evaluate whether the proposed proprietary name WHISPER+ is a…
Evaluate whether the proposed proprietary name WHISPER+ is acceptable for registration for a medicine containing amitriptyline indicated for the treatment of depression. In your answer, clearly state whether the name is acceptable or not and justify your response with reference to the relevant regulatory guideline.
Read Details